Previous Close | 10,790.00 |
Open | 10,884.00 |
Bid | 10,100.00 x 0 |
Ask | 11,000.00 x 0 |
Day's Range | 10,808.00 - 10,932.00 |
52 Week Range | 9,399.00 - 12,828.45 |
Volume | |
Avg. Volume | 2,613,488 |
Market Cap | 174.087B |
Beta (5Y Monthly) | 0.19 |
PE Ratio (TTM) | 50.02 |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | 2.39 (2.14%) |
Ex-Dividend Date | Feb 23, 2023 |
1y Target Est | N/A |
In the latest trading session, Astrazeneca (AZN) closed at $65.61, marking a -0.56% move from the previous day.
There is nothing like a bear market to emphasize the importance of investing in solid, reliable, and steady companies that can deliver consistent revenue and earnings for a long time. Two such companies are AstraZeneca (NASDAQ: AZN) and Visa (NYSE: V). U.K.-based AstraZeneca is a drugmaker with a vast, diversified portfolio of over three-dozen products across six major segments.
Artisan Partners, an investment management company, released its “Artisan Global Equity Fund” fourth quarter 2022 investor letter. A copy of the same can be downloaded here. In the fourth quarter, its Investor Class fund ARTHX returned 15.95%, Advisor Class fund APDHX posted a return of 15.98%, and Institutional Class fund APHHX returned 16.04%, compared to a […]